Extended survival with metastatic pancreatic cancer under fruquintinib treatment after failed chemotherapy: Two case reports

Figure 6 Computed tomography scan of case 2. The computed tomography (CT) scan revealed a continuous partial response from February 23, 2022, to December 7, 2022. A: CT scan showed the target lesion of 51 mm × 46 mm, February 2022; B: CT scan showed the target lesion of 34 mm × 38 mm, April 2022; C: CT scan showed the target lesion of 33 mm × 38 mm, June 2022; D: CT scan showed the target lesion of 35 mm × 31 mm, October 2022; E: CT scan showed the target lesion of 36 mm × 31 mm, December 2022.